{"title":"辅酶Q10:治疗抗磷脂综合征和复发性流产的潜在辅料","authors":"H. Shankar, P. Verma, D. N. Rao","doi":"10.2174/1573395514666180416155458","DOIUrl":null,"url":null,"abstract":"Background: Recurrent Miscarriage (RM) is one of the most frustrating clinical situations wherein most of the cases, neither the engaged obstetrician nor suffering couples know the exact etiology and cause of the disease. About 10-15% of women with RM diagnosed with antiphospholipid syndrome (APS) are characterized by the marked presence of antiphospholipid antibodies (aPLa). There are several scientific reports available on the association between APS and RM; however, scanty data available about the beneficial role of coenzyme Q10 (CoQ10) in APS and APS mediated RM. In the present attempt, we tried to gather information to explain the possible associations between the role of CoQ10 in RM and APS. Methods: We collected peer-reviewed literature using keywords; antiphospholipid syndrome, CoQ10, endothelial dysfunction, oxidative stress and recurrent miscarriage in online electronic databases, such as Web of Science, Science Direct, Google Scholar, PubMed and Medline. The qualitative analysis of content was done by summarizing interventions and findings of included studies, on the basis of which a conceptual framework was prepared for this narrative review. Results: The beneficial role of CoQ10 in diverse pathological conditions has been summarized and the evidence suggests that CoQ10 being a potent antioxidant helps in the amelioration of free radicalmediated aPLa production, endothelial damage and mitochondrial dysfunction. The supplementation of CoQ10 overcomes the immune dysregulation in idiopathic RM and APS; thus could be a possible therapeutic adjunct in such diseases. Conclusion: Based on this review, further comprehensive studies may be conducted to illuminate the beneficial therapeutic effects of supplementing CoQ10 on possible modifiable pathways involved in the progression of RM and APS. A R T I C L E H I S T O R Y Received: December 29, 2017 Revised: April 06, 2018 Accepted: April 14, 2018 DOI: 10.2174/1573395514666180416155458","PeriodicalId":35403,"journal":{"name":"Current Immunology Reviews","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1573395514666180416155458","citationCount":"1","resultStr":"{\"title\":\"Coenzyme Q10: A Potential Adjunct for Treatment of Antiphospholipid Syndrome and Recurrent Miscarriage\",\"authors\":\"H. Shankar, P. Verma, D. N. Rao\",\"doi\":\"10.2174/1573395514666180416155458\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Recurrent Miscarriage (RM) is one of the most frustrating clinical situations wherein most of the cases, neither the engaged obstetrician nor suffering couples know the exact etiology and cause of the disease. About 10-15% of women with RM diagnosed with antiphospholipid syndrome (APS) are characterized by the marked presence of antiphospholipid antibodies (aPLa). There are several scientific reports available on the association between APS and RM; however, scanty data available about the beneficial role of coenzyme Q10 (CoQ10) in APS and APS mediated RM. In the present attempt, we tried to gather information to explain the possible associations between the role of CoQ10 in RM and APS. Methods: We collected peer-reviewed literature using keywords; antiphospholipid syndrome, CoQ10, endothelial dysfunction, oxidative stress and recurrent miscarriage in online electronic databases, such as Web of Science, Science Direct, Google Scholar, PubMed and Medline. The qualitative analysis of content was done by summarizing interventions and findings of included studies, on the basis of which a conceptual framework was prepared for this narrative review. Results: The beneficial role of CoQ10 in diverse pathological conditions has been summarized and the evidence suggests that CoQ10 being a potent antioxidant helps in the amelioration of free radicalmediated aPLa production, endothelial damage and mitochondrial dysfunction. The supplementation of CoQ10 overcomes the immune dysregulation in idiopathic RM and APS; thus could be a possible therapeutic adjunct in such diseases. Conclusion: Based on this review, further comprehensive studies may be conducted to illuminate the beneficial therapeutic effects of supplementing CoQ10 on possible modifiable pathways involved in the progression of RM and APS. A R T I C L E H I S T O R Y Received: December 29, 2017 Revised: April 06, 2018 Accepted: April 14, 2018 DOI: 10.2174/1573395514666180416155458\",\"PeriodicalId\":35403,\"journal\":{\"name\":\"Current Immunology Reviews\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-03-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2174/1573395514666180416155458\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Immunology Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1573395514666180416155458\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Immunology Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573395514666180416155458","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1
摘要
背景:复发性流产(RM)是最令人沮丧的临床情况之一,在大多数情况下,无论是产科医生还是痛苦的夫妇都不知道疾病的确切病因和原因。约10-15%的RM患者被诊断为抗磷脂综合征(APS),其特征是抗磷脂抗体(aPLa)的显著存在。关于APS和RM之间的联系,有几份科学报告;然而,关于辅酶Q10(CoQ10)在APS和APS介导的RM中的有益作用的可用数据很少。在目前的尝试中,我们试图收集信息来解释辅酶Q10在RM和APS中的作用之间的可能关联。方法:我们使用关键词收集同行评审的文献;在线电子数据库中的抗磷脂综合征、辅酶Q10、内皮功能障碍、氧化应激和复发性流产,如Web of Science、Science Direct、Google Scholar、PubMed和Medline。内容的定性分析是通过总结干预措施和纳入研究的结果来完成的,在此基础上为本次叙述性审查准备了一个概念框架。结果:总结了辅酶Q10在各种病理条件下的有益作用,有证据表明,辅酶Q10是一种强效抗氧化剂,有助于改善自由基介导的aPLa产生、内皮损伤和线粒体功能障碍。补充辅酶Q10克服了特发性RM和APS的免疫失调;因此可能是这类疾病的一种可能的辅助治疗手段。结论:在这篇综述的基础上,可以进行进一步的综合研究,以阐明补充辅酶Q10对参与RM和APS进展的可能的可改变途径的有益治疗作用。A R T I C L E H I S T O R Y收到时间:2017年12月29日修订日期:2018年4月6日接受时间:2018年04月14日DOI:10.2174/15739551466180416155458
Coenzyme Q10: A Potential Adjunct for Treatment of Antiphospholipid Syndrome and Recurrent Miscarriage
Background: Recurrent Miscarriage (RM) is one of the most frustrating clinical situations wherein most of the cases, neither the engaged obstetrician nor suffering couples know the exact etiology and cause of the disease. About 10-15% of women with RM diagnosed with antiphospholipid syndrome (APS) are characterized by the marked presence of antiphospholipid antibodies (aPLa). There are several scientific reports available on the association between APS and RM; however, scanty data available about the beneficial role of coenzyme Q10 (CoQ10) in APS and APS mediated RM. In the present attempt, we tried to gather information to explain the possible associations between the role of CoQ10 in RM and APS. Methods: We collected peer-reviewed literature using keywords; antiphospholipid syndrome, CoQ10, endothelial dysfunction, oxidative stress and recurrent miscarriage in online electronic databases, such as Web of Science, Science Direct, Google Scholar, PubMed and Medline. The qualitative analysis of content was done by summarizing interventions and findings of included studies, on the basis of which a conceptual framework was prepared for this narrative review. Results: The beneficial role of CoQ10 in diverse pathological conditions has been summarized and the evidence suggests that CoQ10 being a potent antioxidant helps in the amelioration of free radicalmediated aPLa production, endothelial damage and mitochondrial dysfunction. The supplementation of CoQ10 overcomes the immune dysregulation in idiopathic RM and APS; thus could be a possible therapeutic adjunct in such diseases. Conclusion: Based on this review, further comprehensive studies may be conducted to illuminate the beneficial therapeutic effects of supplementing CoQ10 on possible modifiable pathways involved in the progression of RM and APS. A R T I C L E H I S T O R Y Received: December 29, 2017 Revised: April 06, 2018 Accepted: April 14, 2018 DOI: 10.2174/1573395514666180416155458
期刊介绍:
Current Immunology Reviews publishes frontier reviews on all the latest advances in clinical immunology. The journal"s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in clinical immunology.